of first-time users Agree or
Strongly Agree…that Mostcare
Up is easy to use*
It takes only 60 seconds to setup Mostcare Up, providing you with valuable time when you need it most.
Mostcare Up customers also have quicker visibility of the haemodynamic status of their patients. Meaning they can make faster clinical decisions and see the effect of interventions sooner.
Unlike other haemodynamic monitors, Mostcare Up does not require any calibration and can calculate cardiac output and other key haemodynamic parameters without the need for input of demographic data.
It has an intuitive, customisable interface specifically designed to aid clinician decision making before, during and after interventions.
Mostcare Up provides constant monitoring with accurate and rapid results. Thanks to its modern flexible connections and setup, real-time data can be obtained, saved and transferred for subsequent analysis.
The PRAM™ algorithm is a patented dynamic filter is responsible for producing quality pressure signals of the highest accuracy, consistently.
Mostcare Up is the perfect haemodynamic monitor for clinicians and managers who need a reliable, clinically validated monitor and need a way to reduce revenue.
Our capital business model guarantees no dedicated disposables for your haemodynamic solution. And when we include patients undergoing high risk surgery, your savings are, frankly, enormous.
HL7 compatible to enable data transfer, Mostcare Up can connect to your patient information systems, helping you stay more efficient.
A Patented Algorithm: PRAM
PRAM (Pressure Recording Analytical Method)
PRAM is an innovative method to analyse the pressure wave used in Mostcare UP.
It allows for constant and sensitive monitoring in real time. Monitoring the slightest haemodynamic variations because it is based, heartbeat by heartbeat, only on the morphology of the arterial pressure wave.
No calibration or pre-estimates are required, meaning you can monitor your patients quickly and accurately.
Sampling at 1,000Hz
Following your patient throughout their pathway
Haemodynamic optimisation of critically ill patients has been shown to be a cornerstone of care associated with improved outcomes. Mostcare Up provides minimally invasive continuous advanced variables to help guide therapeutic interventions and identify fluid responsiveness.
“Critically ill patients are often hemodynamically unstable (or at risk of becoming unstable)… With hemodynamic monitoring, we aim to guide our medical management so as to prevent or treat organ failure and improve the outcomes of our patients.”
(Huygh J, Peeters Y, Bernards J, Malbrain ML. Hemodynamic monitoring in the critically ill: an overview of current cardiac output monitoring methods. F1000Res. 2016;5:F1000 Faculty Rev-2855. Published 2016 Dec 16. doi:10.12688/f1000research.8991.1)
Goal-directed therapy in high-risk surgical patients is key to reducing postoperative complications and length of stay. With a quick and easy set-up and continuous customisable trending screens, the Mostcare with its sophisticated patented PRAM algorithm is an effective and accurate device to monitor fluid administration and vasoactive drugs.
Mostcare is suitable for surgical procedures including; emergency, trauma, colorectal, HIPEC, upper-GI, orthopaedic.
“…perioperative hemodynamic optimization (goal-directed therapy) has been demonstrated to reduced the incidence of complication, length of stay, and mortality of surgical patients.”
(Romagnoli et al 2013) (Vy_A46)
The Mostcare Up monitor has been extensively validated in the paediatric population and can be used in the operating theatre or intensive care departments. Simple to set up connection to a peripheral or central arterial cannulation site, values such as cardiac index and systemic vascular resistance can be obtained as a vital additional tool for management of the sickest child.
Mostcare is suitable for many paediatric patients including; scoliosis, LCOS, PICU post-surgical, PICU medical.
“Hemodynamic monitoring is fundamental to the management of the critically ill pediatric patient.”
(Calamandrei et al 2008) (Vy_A11)
Validation in IABP and other cardiac assist devices make Mostcare applicable in a wide range of cardiac patients both in surgery and CICU when more invasive methods may pose a challenge.
“CO estimates obtained by PRAM during cardiac surgery show good agreement with those simultaneously obtained by conventional bolus ThD”
(Giomarelli et al 2004.) (Vy_A04)
High Risk Areas
Mostcare can be used in any area where there is a need for invasive blood pressure monitoring and a risk of haemodynamic instability. It’s simple no calibration set up means that more patients can benefit from advanced monitoring than ever before.
“In patients undergoing vascular surgery…MostCare/PRAM was shown to estimate CO with a good level of agreement with echocardiographic measures.”
(Romagnoli et al. 2013) (Vy_A46)
Patients who present initially at A&E with suspected sepsis require early recognition, treatment and judicious volume resuscitation. The Mostcare Up provides continuous haemodynamic monitoring and stabilisation of the sickest patients who have arterial line placement on admission and facilitates optimal management of shock states.
Transfers of critically ill patients- be they children or adults- can pose unique challenges and MostcareUp with it’s portability and no disposables is an ideal monitor for transport between hospitals.
“…data strongly support a haemodynamically-guided fluid resuscitation strategy in patients with severe sepsis and septic shock… Initial fluid resuscitation should be limited and guided by an assessment of fluid responsiveness.”
Paediatric Key Study:
Treating sepsis in children
For children with sepsis, volume resuscitation is one of the most commonly used therapeutic options.
However, excessive fluid administration may impair tissue perfusion further by promoting oedema and third-space fluid accumulation.
To prevent these issues, not only have guidelines for smaller fluid boluses of 5-10ml/kg been suggested, but ESPNIC* also suggest that the child’s cardiac output changes be tracked, along with blood pressure and CVP to assess fluid responsiveness.
Adult Key Study:
Determining cardiac output in septic patients.
In septic patients, changes in vascular impedance and compliance often occur requiring recalibration of cardiac output monitors.
Mostcare requires no recalibration or adjustment… the Mostcare system was not affected by the vascular tone changes produced by norepinephrine infusion.
Ovarian CRS: Key Study
Within this study, the objective is to determine whether aggressive, goal-directed intra-operative fluid management (GDFM) guided by cardiac output monitoring (COM) has improved patient post operative outcomes. The use of goal-directed haemodynamic therapy during the peri-operative phase, aims to try and match the delivery with the increased demand for oxygen during a major surgical insult.
The study concludes there is a clear suggestion of improvement in patient outcomes and use of finite resources with intra-operative goal-directed fluid management assisted with a cardiac output monitoring device.
“We trialled the Mostcare Vygon cardiac output centre in our trust over a month-long period as we were looking into introducing a new monitoring system.
We were attracted by the Vygon system as it does not require bespoke arterial line consumables meaning that it could be used at any point of a case (if arterial monitoring is already in-situ) and that ongoing expenses should be minimal.
We found the monitoring to be easy to set up, glitch-free and with good monitor screen size. The derived arterial variables are relatively standard compared to other established output monitoring systems and the data produced was certainly reflective of the actual physiology exhibited by patients undergoing a variety of surgical techniques (including laparoscopy). We will be looking into introducing the system into our theatres and look forward getting the most out of the enhanced care it will support”.
Flexibility of Use
We have flexible financial models to suit your needs; whether that may be capital or revenue, we can provide a solution. Mostcare Up does not require additional consumables, so you can use it as much as you want to, and it will never go over.
Allows an unrestricted use of the system without additional cost. This is beneficial for hospitals with a large number of patients who need continually monitoring.
Offering unlimited patient usage for 365 days, with annual card reactivation giving you flexibility to optimise your patient usage with a fixed annual cost
When you need support, we’re there.
Our dedicated Sales Team are on hand to answer any questions and guide you through our product ranges. As specialists in their field, simply contact your Vygon representative to arrange a product demo and let us show you how our Mostcare Up haemodynamic monitoring solution improves your bottom-line performance and patient care.
Our Technical Support Team is home to the experts when it comes to answering questions related to the finer technical detail of our range of medical devices, procedural advice and regulatory device issues, as well as thorough product testing and solutions to help the ongoing use of our products. We understand the devoted and consistent level of service that our customers need so that they can feel confident that any enquiry is dealt with swiftly and professionally.